Synergy between ethanol and grape polyphenols, quercetin, and resveratrol, in the inhibition of the inducible nitric oxide synthase pathway

Biochemical Pharmacology

Volumn 60, Issue 10, 2000, Pages 1539-1548

  Man Ying Chan, Marion ^a,b,c   Mattiacci, John A ^b   Hwang, Hyon S ^c   Shah, Amit ^b   Fong, Dunne ^c  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF PODIATRIC MEDICINE   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

Ethanol; Inducible nitric oxide synthase; Macrophages; Nitric oxide; Quercetin; Resveratrol

Indexed keywords

ALCOHOL; BACTERIUM LIPOPOLYSACCHARIDE; GAMMA INTERFERON; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; POLYPHENOL DERIVATIVE; QUERCETIN; RESVERATROL; SCAVENGER;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CANCER INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ALCOHOL INTERACTION; GRAPE; MACROPHAGE ACTIVATION; MEDIATOR RELEASE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCAVENGING SYSTEM; WINE;

ANIMAL; CELLS, CULTURED; DRUG SYNERGISM; ENZYME INHIBITORS; ETHANOL; GENE EXPRESSION; MACROPHAGES; MICE; NITRIC OXIDE; NITRIC-OXIDE SYNTHASE; PHENOLS; POLYMERS; QUERCETIN; ROSALES; STILBENES; SUPPORT, NON-U.S. GOV'T;

EID: 0034670172     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(00)00471-8     Document Type: Article

References (55)

1. Nathan C. Inducible nitric oxide synthase What difference does it make? J Clin Invest. 100:1997;2417-2423.
2. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide Physiology, pathophysiology, and pharmacology . Pharmacol Rev. 43:1991;109-142.
3. Burney S., Caulfield J.L., Niles J.C., Wishnok J.S., Tannenbaum S.R. The chemistry of DNA damage from nitric oxide and peroxynitrite. Mutat Res. 424:1999;37-49.
4. Wilcox J.N., Subramanian R.R., Sundell C.L., Tracey W.R., Pollock J.S., Harrison D.G., Marsden P.A. Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler Thromb Vasc Biol. 17:1997;2479-2488.
5. MacNaul K.L., Hutchinson N.I. Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions. Biochem Biophys Res Commun. 196:1993;1330-1334.
6. Renaud S., de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 339:1992;1523-1526.
7. Trichopoulou A., Lagiou P. Healthy traditional Mediterranean diet, An expression of culture, history, and lifestyle. Nutr Rev. 55:1997;383-389.
8. Gronbaek M., Deis A., Sorensen T.I., Becker U., Schnohr P., Jensen G. Mortality associated with moderate intakes of wine, beer, or spirits. BMJ. 310:1995;1165-1169.
9. Rimm E.B., Klatsky A., Grobbee D., Stampfer M.J. Review of moderate alcohol consumption and reduced risk of coronary heart disease Is the effect due to beer, wine, or spirits? BMJ. 312:1996;731-736.
10. Clifford A.J., Ebeler S.E., Ebeler J.D., Bills N.D., Hinrichs S.H., Teissedre P.L., Waterhouse A.L. Delayed tumor onset in transgenic mice fed an amino acid-based diet supplemented with red wine solids. Am J Clin Nutr. 64:1996;748-756.
11. Hertog M.G., Hollman P.C. Potential health effects of the dietary flavonol quercetin. Eur J Clin Nutr. 50:1996;63-71.
12. Soleas G.J., Diamandis E.P., Goldberg D.M. Resveratrol A molecule whose time has come? And gone? Clin Biochem. 30:1997;91-113.
13. Formica J.V., Regelson W. Review of the biology of quercetin and related bioflavonoids. Food Chem Toxicol. 33:1995;1061-1080.
14. Kuo S.M. Dietary flavonoid and cancer prevention Evidence and potential mechanism . Crit Rev Oncog. 8:1997;47-69.
15. Brouillard R., George F., Fougerousse A. Polyphenols produced during red wine ageing. Biofactors. 6:1997;403-410.
16. Rice-Evans C.A., Packer L. Flavonoids in Health and Disease. 1998;Marcel Dekker, New York.
17. Safety assessment and potential health benefits of food components based on selected scientific criteria. ILSI North America Technical Committee on Food Components for Health Promotion. Crit Rev Food Sci Nutr. 39:1999;203-316.
18. Lin J.K., Tsai S.H. Chemoprevention of cancer and cardiovascular disease by resveratrol. Proc Natl Sci Counc Repub China B. 23:1999;99-106.
19. Kawada N., Seki S., Inoue M., Kuroki T. Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells. Hepatology. 27:1998;1265-1274.
20. Soliman K.F., Mazzio E.A. In vitro attenuation of nitric oxide production in C6 astrocyte cell culture by various dietary compounds. Proc Soc Exp Biol Med. 218:1998;390-397.
21. Tsai S.H., Lin-Shiau S.Y., Lin J.K. Suppression of nitric oxide synthase and the down-regulation of the activation of NFκB in macrophages by resveratrol. Br J Pharmacol. 126:1999;673-680.
22. Wadsworth T.L., Koop D.R. Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages. Biochem Pharmacol. 57:1999;941-949.
23. Kim H.K., Cheon B.S., Kim Y.H., Kim S.Y., Kim H.P. Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationships. Biochem Pharmacol. 58:1999;759-765.
24. Fitzpatrick D.F., Hirschfield S.L., Coffey R.G. Endothelium-dependent vasorelaxing activity of wine and other grape products. Am J Physiol. 265:1993;H774-H778.
25. Andriambeloson E., Kleschyov A.L., Muller B., Beretz A., Stoclet J.C., Andriantsitohaina R. Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta. Br J Pharmacol. 120:1997;1053-1058.
26. Chen C.K., Pace-Asciak C.R. Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. Gen Pharmacol. 27:1996;363-366.
27. Cishek M.B., Galloway M.T., Karim M., German J.B., Kappagoda C.T. Effect of red wine on endothelium-dependent relaxation in rabbits. Clin Sci. 93:1997;507-511.
28. Flesch M., Schwarz A., Bohm M. Effects of red and white wine on endothelium-dependent vasorelaxation of rat aorta and human coronary arteries. Am J Physiol. 275:1998;H1183-H1190.
29. Brouet I., Ohshima H. Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem Biophys Res Commun. 206:1995;533-540.
30. Kobuchi H., Droy-Lefaix M.T., Christen Y., Packer L. Ginkgo biloba extract (EGb 761) Inhibitory effect on nitric oxide production in the macrophage cell line RAW 264.7 . Biochem Pharmacol. 53:1997;897-903.
31. Chan M.M., Fong D., Ho C.T., Huang H.I. Inhibition of inducible nitric oxide synthase gene expression and enzyme activity by epigallocatechin gallate, a natural product from green tea. Biochem Pharmacol. 54:1997;1281-1286.
32. Chan M.M., Huang H.I., Fenton M.R., Fong D. In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. Biochem Pharmacol. 55:1998;1955-1962.
33. Sreejayan and Rao MN, Nitric oxide scavenging by curcuminoids. J Pharm Pharmacol 49: 105-107, 1997.
34. Marcocci L., Maguire J.J., Droy-Lefaix M.T., Packer L. The nitric oxide-scavenging properties of Ginkgo biloba extract EGb 761. Biochem Biophys Res Commun. 201:1994;748-755.
35. Chan M.M., Ho C.T., Huang H.I. Effects of three dietary phytochemicals from tea, rosemary and turmeric on inflammation-induced nitrite production. Cancer Lett. 96:1995;23-29.
36. 15N]nitrate in biological fluids. Anal Biochem. 126:1982;131-138.
37. Mosmann T. Rapid colorimetric assay for cellular growth and survival Application to proliferation and cytotoxicity assays . J Immunol Methods. 65:1983;55-63.
38. Deaciuc I.V. Alcohol and cytokine networks. Alcohol. 14:1997;421-430.
39. Zhao X., Jie O., Li H., Xie J., Giles T.D., Greenberg S.S. Ethanol inhibits inducible nitric oxide synthase transcription and post-transcriptional processes in vivo. Alcohol Clin Exp Res. 21:1997;1246-1256.
40. Syapin P.J. Alcohol and nitric oxide production by cells of the brain. Alcohol. 16:1998;159-165.
41. Greenberg S.S., Jie O., Zhao X., Wang J.F., Giles T.D. The potential mechanism of induction of inducible nitric oxide synthase mRNA in alveolar macrophages by lipopolysaccharide and its suppression by ethanol, in vivo. Alcohol Clin Exp Res. 22:1998;260S-265S.
42. Soleas G.J., Diamandis E.P., Goldberg D.M. Wine as a biological fluid History, production, and role in disease prevention . J Clin Lab Anal. 11:1997;287-313.
43. Serafini M., Maiani G., Ferroluzzi A. Effect of ethanol on red wine tannin-protein (BSA) interactions. J Agric Food Chem. 45:1997;3148-3151.
44. Liang J.F., Akaike T. Inhibition of lipopolysaccharide and cytokine mixture-mediated hepatocyte nitric oxide synthesis by dimethyl sulfoxide. Biochem Biophys Res Commun. 239:1997;517-521.
45. Decker E.A. Phenolics Prooxidants or antioxidants? Nutr Rev. 55:1997;396-398.
46. Ohshima H., Yoshie Y., Auriol S., Gilibert I. Antioxidant and pro-oxidant actions of flavonoids Effects on DNA damage induced by nitric oxide, peroxynitrite and nitroxyl anion . Free Radic Biol Med. 25:1998;1057-1065.
47. Chan M.M., Fong D. Modulation of the nitric oxide pathway by natural products. Laskin J., Laskin D. Cellular and Molecular Biology of Nitric Oxide. 1999;333-351 Marcel Dekker, New York.
48. van Acker S.A., Tromp M.N., Haenen G.R., van der Vijgh W.J., Bast A. Flavonoids as scavengers of nitric oxide radical. Biochem Biophys Res Commun. 214:1995;755-759.
49. ·-) production in murine macrophages by flavones. Biochem Pharmacol. 50:1995;1031-1035.
50. Chiesi M., Schwaller R. Inhibition of constitutive endothelial NO-synthase activity by tannin and quercetin. Biochem Pharmacol. 49:1995;495-501.
51. 2. Cancer Res. 59:1999;2596-2601.
52. Venkov C.D., Myers P.R., Tanner M.A., Su M., Vaughan D.E. Ethanol increases endothelial nitric oxide production through modulation of nitric oxide synthase expression. Thromb Haemost. 81:1999;638-642.
53. Wattanapitayakul S.K., Weinstein D.M., Holycross B.J., Bauer J.A. Endothelial dysfunction and peroxynitrite formation are early events in angiotensin-induced cardiovascular disorders. FASEB J. 14:2000;271-278.
54. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 275:1997;218-220.
55. Subbaramaiah K., Chung W.J., Michaluart P., Telang N., Tanabe T., Inoue H., Jang M., Pezzuto J.M., Dannenberg A.J. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem. 273:1998;21875-21882.